Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients

Lucy R. Baldeón, Karin Weigelt, Harm De Wit, Behiye Ozcan, Adri Van Oudenaren, Fernando Sempértegui, Eric Sijbrands, Laura Grosse, Wilma Freire, Hemmo A. Drexhage, Pieter J.M. Leenen

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

100 Citas (Scopus)


Background: There is increasing evidence that chronic inflammation is an important determinant in insulin resistance and in the pathogenesis of type 2 diabetes (T2D). MicroRNAs constitute a newly discovered system of cell regulation and in particular two microRNAs (miR-146a and miR-155) have been described as regulators and biomarkers of inflammation. Aim: To determine a putative association between the levels of miR-146a and miR-155 in serum of T2D patients, clinical parameters and serological indicators of inflammation. Methods: We performed quantitative Real Time PCR (qPCR) of microRNAs from serum (56 Ecuadorian T2D ambulatory patients and 40 non-diabetic controls). In addition, we evaluated T2D-related serum cytokines.chemokines and growth factors using a commercially available multi-analyte cytometric bead array system. We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state. Results: The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients. - The serum levels of miR-146a were significantly reduced in T2D patients as compared to these non-diabetic, but obese/dyslipidemic control group (mean patients 0.61, mean controls set at 1; p=0.042), those of miR-155 were normal. - The serum levels of both microRNAs correlated to each other (r=0.478; p<0.001) and to leptin levels. The microRNAs did not correlate to BMI, glycemia and dyslipidemia. - From the tested cytokines, chemokines and growth factors, we found IL-8 and HGF significantly raised in T2D patients versus non-diabetic controls (p=0.011 and 0.023 respectively). Conclusions: This study shows decreased serum anti-inflammatory miR-146a, increased pro-inflammatory IL-8 and increased HGF (a vascular/insular repair factor) as discriminating markers of failure of glucose control occurring on the background of obesity and dyslipidemia.

Idioma originalInglés
Número de artículoe115209
PublicaciónPLoS ONE
EstadoPublicada - 12 dic. 2014


Profundice en los temas de investigación de 'Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients'. En conjunto forman una huella única.

Citar esto